ID

35257

Descripción

Study ID: 102970 Clinical Study ID: 102970 Study Title: A 52-week Efficacy and Safety Study to Compare the Effect of Three Dosage Strengths of Fluticasone Furoate/GW642444 Inhalation Powder With GW642444 on the Annual Rate of Exacerbations in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01017952 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: GW642444 Inhalation Powder; FF/GW642444 Inhalation Powder Trade Name: Fluticasone Furoate;Fluticasone Propionate;Fluticasone Propionate/Salmeterol;Salmeterol;Vilanterol Study Indication: Pulmonary Disease, Chronic Obstructive

Palabras clave

Versiones (1)
  1. 25/2/19 25/2/19 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

25 de febrero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Effect of Fluticasone Furoate/GW642444 Inhalation Powder With GW642444 on Annual Rate of Exacerbations in Subjects with COPD; 102970

Inglés

End of Study

1 formularios  
  1. StudyEvent: ODM
    1. End of Study
Administrative Data
Descripción

Administrative Data

Site
Descripción

Study Site

Tipo de datos

text

Alias
UMLS CUI [1]
C2825164
Subject
Descripción

Clinical trial participant

Tipo de datos

text

Alias
UMLS CUI [1]
C1997894
Subject No.
Descripción

Clinical Trial Subject Unique Identifier

Tipo de datos

integer

Alias
UMLS CUI [1]
C2348585
Status of Treatment Blind
Descripción

Status of Treatment Blind

Alias
UMLS CUI-1
C2347038
UMLS CUI-2
C0449438
Was the treatment blind broken during the study?
Descripción

If yes, complete Non-Serious Adverse Events, Serious Adverse Event and/or Investigational Product forms as appropriate

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3897431
Date blind broken
Descripción

Subject Unblinding Event Record, Date in time

Tipo de datos

date

Alias
UMLS CUI [1,1]
C3897431
UMLS CUI [1,2]
C0011008
Reason blind broken
Descripción

Subject Unblinding Event Record, Indication

Tipo de datos

text

Alias
UMLS CUI [1,1]
C3897431
UMLS CUI [1,2]
C0392360
Follow-Up Contact
Descripción

Follow-Up Contact

Alias
UMLS CUI-1
C1522577
Subject contacted for follow-up?
Descripción

Follow-up, Contact with, Study subject

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1522577
UMLS CUI [1,2]
C0332158
UMLS CUI [1,3]
C0681850
Date of Visit/Assessment
Descripción

Date of Visit/Assessment

Alias
UMLS CUI-1
C1320303
UMLS CUI-2
C2985720
Date of visit/assessment
Descripción

Date of visit, Assessment Date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C1320303
UMLS CUI [1,2]
C2985720
Study Conclusion
Descripción

Study Conclusion

Alias
UMLS CUI-1
C0008976
UMLS CUI-2
C1707478
Date of subject completion or withdrawal
Descripción

Study End Date, Patient withdrawn from trial, Date in time

Tipo de datos

date

Alias
UMLS CUI [1,1]
C2983670
UMLS CUI [1,2]
C0422727
UMLS CUI [1,3]
C0011008
Was the subject withdrawn from the study?
Descripción

Patient withdrawn from trial

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0422727
Primary reason for withdrawal
Descripción

Patient withdrawn from trial, Indication

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C3146298
Investigational Product - Double Blind
Descripción

Investigational Product - Double Blind

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C0013072
Start Date
Descripción

Experimental drug, Double-Blind Method, Start Date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0013072
UMLS CUI [1,2]
C0808070
UMLS CUI [1,3]
C0808070
Stop Date
Descripción

Experimental drug, Double-Blind Method, End Date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0013072
UMLS CUI [1,2]
C0808070
UMLS CUI [1,3]
C0806020
Pharmacogenetic (PGx) Research Withdrawal of Consent
Descripción

Pharmacogenetic (PGx) Research Withdrawal of Consent

Alias
UMLS CUI-1
C0031325
UMLS CUI-2
C1707492
Has subject withdrawn consent for PGx research?
Descripción

Pharmacogenetics, Consent Withdrawn

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0031325
UMLS CUI [1,2]
C1707492
Yes, date informed consent withdrawn
Descripción

Pharmacogenetics, Consent Withdrawn, Date in time

Tipo de datos

date

Alias
UMLS CUI [1,1]
C2347500
UMLS CUI [1,2]
C1707492
UMLS CUI [1,3]
C0011008
Has a request been made for sample destruction?
Descripción

Pharmacogenetics, Blood Specimen, Destruction, Request

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0031325
UMLS CUI [1,2]
C0178913
UMLS CUI [1,3]
C1948029
UMLS CUI [1,4]
C1272683
Yes, check reason
Descripción

Pharmacogenetics, Blood Specimen, Destruction, Request, Indication

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0031325
UMLS CUI [1,2]
C0178913
UMLS CUI [1,3]
C1948029
UMLS CUI [1,4]
C1272683
UMLS CUI [1,5]
C3146298
Investigator Signature
Descripción

Investigator Signature

Alias
UMLS CUI-1
C2346576
Is this casebook ready to sign?
Descripción

Investigator Signature

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2346576
Pregnancy Information
Descripción

Pregnancy Information

Alias
UMLS CUI-1
C0032961
UMLS CUI-2
C1533716
Did the subject become pregnant during the study?
Descripción

Pregnant during the study

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3828490
Volver a la parte superior de la página

Similar models

End of Study

1 formularios
  1. StudyEvent: ODM
    1. End of Study
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Administrative Data
Study Site
Item
Site
text
C2825164 (UMLS CUI [1])
Clinical trial participant
Item
Subject
text
C1997894 (UMLS CUI [1])
Clinical Trial Subject Unique Identifier
Item
Subject No.
integer
C2348585 (UMLS CUI [1])
Item Group
Status of Treatment Blind
C2347038 (UMLS CUI-1)
C0449438 (UMLS CUI-2)
Subject Unblinding Event Record
Item
Was the treatment blind broken during the study?
boolean
C3897431 (UMLS CUI [1])
Subject Unblinding Event Record, Date in time
Item
Date blind broken
date
C3897431 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item
Reason blind broken
text
C3897431 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
Subject Unblinding Event Record, Indication
Code List
Reason blind broken
CL Item
Medical emergency requiring identification of investigational product for further treatment (1)
CL Item
Other, specify (2)
Item Group
Follow-Up Contact
C1522577 (UMLS CUI-1)
Follow-up, Contact with, Study subject
Item
Subject contacted for follow-up?
boolean
C1522577 (UMLS CUI [1,1])
C0332158 (UMLS CUI [1,2])
C0681850 (UMLS CUI [1,3])
Item Group
Date of Visit/Assessment
C1320303 (UMLS CUI-1)
C2985720 (UMLS CUI-2)
Date of visit, Assessment Date
Item
Date of visit/assessment
date
C1320303 (UMLS CUI [1,1])
C2985720 (UMLS CUI [1,2])
Item Group
Study Conclusion
C0008976 (UMLS CUI-1)
C1707478 (UMLS CUI-2)
Study End Date, Patient withdrawn from trial, Date in time
Item
Date of subject completion or withdrawal
date
C2983670 (UMLS CUI [1,1])
C0422727 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Patient withdrawn from trial
Item
Was the subject withdrawn from the study?
boolean
C0422727 (UMLS CUI [1])
Item
Primary reason for withdrawal
text
C0422727 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
Patient withdrawn from trial, Indication
Code List
Primary reason for withdrawal
CL Item
Adverse Event (1)
CL Item
Lack of efficacy  (2)
CL Item
Exacerbation (3)
CL Item
Protocol Deviation (4)
CL Item
Subject reached protocol defined stopping criteria  (5)
CL Item
Study closed/terminated (6)
CL Item
Lost to Follow-up (7)
CL Item
Withdrew consent (8)
CL Item
Investigator discretion, specify (9)
Item Group
Investigational Product - Double Blind
C0304229 (UMLS CUI-1)
C0013072 (UMLS CUI-2)
Experimental drug, Double-Blind Method, Start Date
Item
Start Date
date
C0013072 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,3])
Experimental drug, Double-Blind Method, End Date
Item
Stop Date
date
C0013072 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,3])
Item Group
Pharmacogenetic (PGx) Research Withdrawal of Consent
C0031325 (UMLS CUI-1)
C1707492 (UMLS CUI-2)
Pharmacogenetics, Consent Withdrawn
Item
Has subject withdrawn consent for PGx research?
boolean
C0031325 (UMLS CUI [1,1])
C1707492 (UMLS CUI [1,2])
Pharmacogenetics, Consent Withdrawn, Date in time
Item
Yes, date informed consent withdrawn
date
C2347500 (UMLS CUI [1,1])
C1707492 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Pharmacogenetics, Blood Specimen, Destruction, Request
Item
Has a request been made for sample destruction?
boolean
C0031325 (UMLS CUI [1,1])
C0178913 (UMLS CUI [1,2])
C1948029 (UMLS CUI [1,3])
C1272683 (UMLS CUI [1,4])
Item
Yes, check reason
text
C0031325 (UMLS CUI [1,1])
C0178913 (UMLS CUI [1,2])
C1948029 (UMLS CUI [1,3])
C1272683 (UMLS CUI [1,4])
C3146298 (UMLS CUI [1,5])
Pharmacogenetics, Blood Specimen, Destruction, Request, Indication
Code List
Yes, check reason
CL Item
Subject withdrew consent for PGx  (1)
CL Item
Screen failure (2)
CL Item
Other, specify (3)
Item Group
Investigator Signature
C2346576 (UMLS CUI-1)
Investigator Signature
Item
Is this casebook ready to sign?
boolean
C2346576 (UMLS CUI [1])
Item Group
Pregnancy Information
C0032961 (UMLS CUI-1)
C1533716 (UMLS CUI-2)
Pregnant during the study
Item
Did the subject become pregnant during the study?
boolean
C3828490 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial